Case Reports in Oncological Medicine最新文献

筛选
英文 中文
Malignant Melanoma Arising in a Congenital Melanocytic Nevus in Early Infancy With Fatal Metastatic Progression: A Case Report. 恶性黑色素瘤发生在先天性黑素细胞痣早期婴儿致命的转移进展:1例报告。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-11-14 eCollection Date: 2026-01-01 DOI: 10.1155/crom/1159345
Rasoul Goli, Nasrin Karimi, Fereshteh Seyed Mohammad Shahi, Ali Soheyli
{"title":"Malignant Melanoma Arising in a Congenital Melanocytic Nevus in Early Infancy With Fatal Metastatic Progression: A Case Report.","authors":"Rasoul Goli, Nasrin Karimi, Fereshteh Seyed Mohammad Shahi, Ali Soheyli","doi":"10.1155/crom/1159345","DOIUrl":"https://doi.org/10.1155/crom/1159345","url":null,"abstract":"<p><p>Malignant melanoma arising within a congenital melanocytic nevus (CMN) during early infancy is rare and presents substantial diagnostic and therapeutic challenges. We report a male infant with a congenital pigmented lesion on the right cheek that developed progressive darkening, rapid enlargement, nodularity, ulceration, and intermittent bleeding during the first 3 months of life. Histopathological examination revealed melanoma associated with a CMN, with a Breslow thickness of 2.5 mm and ulceration. Distinguishing melanoma from a benign proliferative nodule was a central diagnostic consideration. Surgical excision was performed at 4 months of age, with microscopically negative margins. The facial location complicated surgical planning, and omission of sentinel lymph node biopsy left pathological nodal status undetermined. Although no recurrence or metastatic disease was detected during the initial 6 months of postoperative follow-up, the child subsequently died. This case highlights the diagnostic complexity and potentially serious outcomes of melanoma arising in CMN during infancy. It emphasizes the importance of prompt assessment of changing congenital lesions, expert histopathological review, multidisciplinary management, and prolonged surveillance. An initially reassuring postoperative assessment should not be interpreted as evidence of durable disease control.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"1159345"},"PeriodicalIF":0.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768850/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orbital Diffuse Large B-Cell Lymphoma Masquerading as Periorbital Cellulitis in a Paediatric Patient With Ataxia-Telangiectasia: A Case Report. 眼眶弥漫性大b细胞淋巴瘤伪装成眼眶周围蜂窝织炎在儿童患者的共济失调毛细血管扩张:1例报告。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-11-09 eCollection Date: 2026-01-01 DOI: 10.1155/crom/7092035
Fajer Alabdulrazzaq, Arwa Alkanderi, Bashayer AlHazeem, Abdullah Alenezi
{"title":"Orbital Diffuse Large B-Cell Lymphoma Masquerading as Periorbital Cellulitis in a Paediatric Patient With Ataxia-Telangiectasia: A Case Report.","authors":"Fajer Alabdulrazzaq, Arwa Alkanderi, Bashayer AlHazeem, Abdullah Alenezi","doi":"10.1155/crom/7092035","DOIUrl":"10.1155/crom/7092035","url":null,"abstract":"<p><p>Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder characterised by cerebellar ataxia, combined immunodeficiency and elevated predisposition to lymphoid malignancy, rendering orbital malignancy clinically and radiologically indistinguishable from infection. We report a 7-year-old female with A-T presenting with left periorbital cellulitis unresponsive to prolonged antimicrobial therapy, surgical drainage and antifungal escalation. Incisional biopsy of a persistent periorbital mass revealed diffuse large B-cell lymphoma (DLBCL), confirmed on immunohistochemistry. Staging indicated Lugano-modified Ann Arbour Stage IV disease, with a primary orbital mass and non-contiguous mediastinal and abdominal disease on cross-sectional imaging. Bone marrow assessment showed no morphological involvement, although flow cytometry detected a light chain-restricted B-cell population. The pulmonary lesions could not be radiologically distinguished from necrotising infection. She received R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone) with cyclophosphamide and vincristine reduced to approximately 50% of standard doses but died approximately 2 months after diagnosis, following a severe necrotising pulmonary infection after the second treatment cycle. This case underscores the importance of early malignancy consideration in immunocompromised A-T patients with refractory orbital disease, the critical role of timely tissue biopsy and the diagnostic difficulty of distinguishing lymphomatous involvement from infection on imaging alone in this population.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"7092035"},"PeriodicalIF":0.6,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13748810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant FOLFOXIRI in a Locally Advanced Right Colon Cancer Patient: A Case Report From a Limited-Resource Setting. 新辅助FOLFOXIRI在局部晚期右结肠癌患者中的应用:来自有限资源环境的一例报告。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-11-06 eCollection Date: 2026-01-01 DOI: 10.1155/crom/5532415
Osama Alazka, Rita Mohammad, Haya Alreem Saied, Hamza Abedallaa, Nader Abedallaa
{"title":"Neoadjuvant FOLFOXIRI in a Locally Advanced Right Colon Cancer Patient: A Case Report From a Limited-Resource Setting.","authors":"Osama Alazka, Rita Mohammad, Haya Alreem Saied, Hamza Abedallaa, Nader Abedallaa","doi":"10.1155/crom/5532415","DOIUrl":"10.1155/crom/5532415","url":null,"abstract":"<p><strong>Background: </strong>Although upfront surgery followed by adjuvant chemotherapy is the standard of care for locally advanced colon cancer (LACC), high rates of recurrence and surgical morbidity remain significant challenges in bulky T4 tumors. Neoadjuvant chemotherapy (NAC) is gaining traction to improve downstaging and resectability. Although doublet regimens (FOLFOX/CAPOX) are established, the use of the intensive triplet regimen FOLFOXIRI in the neoadjuvant setting for nonmetastatic LACC is less common because of toxicity concerns and limited clinical data.</p><p><strong>Case presentation: </strong>A 55-year-old male presented with a bulky, obstructive, right-sided colonic mass (cT4bN+M0). Given the high-risk features and the need for significant cytoreduction in a resource-limited setting where molecular profiling was unavailable, neoadjuvant FOLFOXIRI was initiated. After six cycles, the patient achieved an 85% reduction in tumor volume and normalization of tumor markers (CEA/CA19-9). Despite experiencing manageable Grade 3 neutropenia and anorexia, he underwent successful R0 resection. Histopathology confirmed significant downstaging to ypT2pN0 (0/12), reflecting a near-complete pathological response. Following four cycles of adjuvant CAPOX, the patient remains disease-free at 1.5 years.</p><p><strong>Conclusion: </strong>Neoadjuvant FOLFOXIRI can achieve significant downstaging in bulky tumors and facilitates R0 resection in selected high-risk LACC patients, even in resource-limited settings. Despite requiring careful management of treatment toxicities, triplet NAC offers exploratory, hypothesis-generating option for first colon cancer patients with T4 primary tumors, and can be further supported with future large clinical data.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"5532415"},"PeriodicalIF":0.6,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13743631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colonic Recurrence of Clear Cell Renal Cell Carcinoma 13 Years After Nephrectomy: A Case Report. 透明细胞肾细胞癌切除术后13年结肠复发1例。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-10-26 eCollection Date: 2026-01-01 DOI: 10.1155/crom/6822885
Ivo Klarin
{"title":"Colonic Recurrence of Clear Cell Renal Cell Carcinoma 13 Years After Nephrectomy: A Case Report.","authors":"Ivo Klarin","doi":"10.1155/crom/6822885","DOIUrl":"10.1155/crom/6822885","url":null,"abstract":"<p><p>The colon is a rare site of solitary metastasis from renal cell carcinoma. It may present years after curative resection of the primary tumor, usually with colonic obstruction or gastrointestinal bleeding. We report the case of an 82-year-old man with colon metastasis 13 years after curative nephrectomy for renal cell carcinoma.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"6822885"},"PeriodicalIF":0.6,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13700105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Multiple Recurrent Parasitic Leiomyomas Managed Surgically Without Additional Chemical Estrogen Suppression. 一例罕见的多发性复发性寄生虫性平滑肌瘤手术治疗,无需额外的化学雌激素抑制。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-10-21 eCollection Date: 2026-01-01 DOI: 10.1155/crom/5552760
Claire Baptiste, Elise N Everett, Hibba Tul Rehman, Alexandra Fenton, Bronwyn Bryant, Jessica Cintolo-Gonzalez
{"title":"A Rare Case of Multiple Recurrent Parasitic Leiomyomas Managed Surgically Without Additional Chemical Estrogen Suppression.","authors":"Claire Baptiste, Elise N Everett, Hibba Tul Rehman, Alexandra Fenton, Bronwyn Bryant, Jessica Cintolo-Gonzalez","doi":"10.1155/crom/5552760","DOIUrl":"https://doi.org/10.1155/crom/5552760","url":null,"abstract":"<p><p>Parasitic leiomyomas (PMs) are rare extrauterine benign smooth muscle tumors that can arise spontaneously or develop iatrogenically following prior uterine surgery, particularly with morcellation of uterine tissue. We present a case of a 49-year-old woman who developed multiple recurrent PMs involving the abdominal cavity, appendix, and abdominal wall over several years following laparoscopic myomectomy with morcellation and subsequent hysterectomy. At her most recent intra-abdominal recurrence, she underwent a bilateral oophorectomy at the time of tumor resection. This case highlights the potential for delayed recurrence of parasitic myomas even years after hysterectomy and supports the importance of clinical vigilance and imaging in symptomatic patients with prior morcellation. It also supports consideration of and further study of the role of estrogen suppression in preventing recurrence.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"5552760"},"PeriodicalIF":0.6,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149262963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolated Cervical Seminoma Without Testicular or Mediastinal Primary: A Rare Extragonadal Germ Cell Tumor Presentation. 无睾丸或纵隔原发的分离性宫颈精原细胞瘤:一种罕见的生殖道外生殖细胞肿瘤。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-09-23 eCollection Date: 2026-01-01 DOI: 10.1155/crom/5148074
Nikita Jhangiani, Saivaroon Gajagowni, Joanna Song, Gloria Mensah, Sergio Villegas De Leon, Michael Glover, Son Viet Nguyen
{"title":"Isolated Cervical Seminoma Without Testicular or Mediastinal Primary: A Rare Extragonadal Germ Cell Tumor Presentation.","authors":"Nikita Jhangiani, Saivaroon Gajagowni, Joanna Song, Gloria Mensah, Sergio Villegas De Leon, Michael Glover, Son Viet Nguyen","doi":"10.1155/crom/5148074","DOIUrl":"10.1155/crom/5148074","url":null,"abstract":"<p><p>Germ cell tumors (GCTs) most commonly arise in the testes, with 1%-5% occurring at extragonadal sites, typically along the midline such as the mediastinum or retroperitoneum. We present a case of an exceptionally rare extragonadal seminoma confined to the cervical lymph nodes. Given the atypical location, diagnosis was difficult and required multiple biopsies to ensure appropriate correlation with histologic, immunophenotypic, and cytogenetic findings. Detection of 12p gain by FISH was pivotal in confirming germ cell origin. This case emphasizes the importance of maintaining a broad differential for atypical lymphadenopathy and will review the diagnostic challenge provided by this presentation.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"5148074"},"PeriodicalIF":0.6,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13601731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149036624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic Resection With Hyperthermic Intrathoracic Perfusion Chemotherapy for Thymoma Recurrence. 胸腺瘤复发的机器人切除加胸内热灌注化疗。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-09-12 eCollection Date: 2026-01-01 DOI: 10.1155/crom/1802396
Paula Duarte D Ambrosio, Gustavo Schvartsman, Mathias de Souza Ribeiro, Enzo Campedelli Borges, Marina Cardoso de Castro, Paulo Manuel Pêgo Fernandes, Ricardo Mingarini Terra
{"title":"Robotic Resection With Hyperthermic Intrathoracic Perfusion Chemotherapy for Thymoma Recurrence.","authors":"Paula Duarte D Ambrosio, Gustavo Schvartsman, Mathias de Souza Ribeiro, Enzo Campedelli Borges, Marina Cardoso de Castro, Paulo Manuel Pêgo Fernandes, Ricardo Mingarini Terra","doi":"10.1155/crom/1802396","DOIUrl":"10.1155/crom/1802396","url":null,"abstract":"<p><p>Thymoma recurrence with pleural dissemination remains a therapeutic challenge, often requiring multimodal treatment strategies. Cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy (HITHOC) has emerged as a promising approach for selected patients; however, reports using minimally invasive robotic platforms are limited. We present the case of a 41-year-old woman with pleural and lymph node recurrence of type AB thymoma 3 years after robotic extended thymectomy. The patient underwent robotic-assisted cytoreductive surgery, including complete parietal pleurectomy and resection of pleural, pericardial, and subaortic lymph node lesions, followed by HITHOC with cisplatin and doxorubicin. The procedure was performed safely, with no major perioperative complications. The patient was discharged after 7 days and remained disease-free at 2-year follow-up. This case highlights the feasibility, safety, and potential oncological benefits of combining robotic cytoreductive surgery with HITHOC in the management of recurrent thymoma with pleural involvement. This minimally invasive multimodal strategy may represent a valuable option for carefully selected patients, although further studies with larger cohorts and longer follow-up are warranted.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"1802396"},"PeriodicalIF":0.6,"publicationDate":"2026-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13570410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148954860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paraneoplastic Fever in a Patient With Cervical Carcinoma: A Diagnostic Challenge and Management Approach. 宫颈癌患者的副肿瘤热:诊断挑战和管理方法。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-09-10 eCollection Date: 2026-01-01 DOI: 10.1155/crom/6473606
Ingrid Masilenge, Lucylight Mallya, Ravinder Jandwa, Samwel Mallango, Queen Tarimo, Kezia Tessua, Alita Mrema
{"title":"Paraneoplastic Fever in a Patient With Cervical Carcinoma: A Diagnostic Challenge and Management Approach.","authors":"Ingrid Masilenge, Lucylight Mallya, Ravinder Jandwa, Samwel Mallango, Queen Tarimo, Kezia Tessua, Alita Mrema","doi":"10.1155/crom/6473606","DOIUrl":"10.1155/crom/6473606","url":null,"abstract":"<p><strong>Introduction: </strong>Persistent fever in patients with cancer presents a significant diagnostic challenge, particularly in settings where infectious diseases are highly prevalent. Neoplastic fever is an important noninfectious cause of fever that may mimic infection and result in unnecessary investigations, antimicrobial therapy, and delays in cancer treatment.</p><p><strong>Case presentation: </strong>We report a case of a 45-year-old female patient with advanced cervical carcinoma who presented with persistent high-grade fever unresponsive to antibiotics. An extensive infectious workup was negative. Following exclusion of alternative causes, a naproxen challenge was performed, resulting in rapid resolution of fever within 24 h. Fever recurred upon withdrawal and resolved again after naproxen reintroduction, supporting the diagnosis of neoplastic fever.</p><p><strong>Conclusion: </strong>Neoplastic fever should be considered early in cancer patients with persistent unexplained fever, particularly in tuberculosis- and malaria-endemic settings. Following exclusion of infection, the naproxen challenge may provide a simple and affordable diagnostic step to distinguish neoplastic fever from infectious causes, reduce unnecessary antimicrobial use, shorten diagnostic delays, and facilitate timely cancer-directed therapy.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"6473606"},"PeriodicalIF":0.6,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13559711/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148944219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lenalidomide-Associated Rhabdomyolysis Progressing to Bilateral Compartment Syndrome and Permanent Foot Drop. 来那度胺相关横纹肌溶解进展为双侧筋膜室综合征和永久性足下垂。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-09-07 eCollection Date: 2026-01-01 DOI: 10.1155/crom/6693120
Karthik Iyer, Sanjna Chetan, Anoohya Arkala, Craig S Siegel, Bhaskara Gadi, Cristian Popu, Vikram Oke, Briccio S Cadiz
{"title":"Lenalidomide-Associated Rhabdomyolysis Progressing to Bilateral Compartment Syndrome and Permanent Foot Drop.","authors":"Karthik Iyer, Sanjna Chetan, Anoohya Arkala, Craig S Siegel, Bhaskara Gadi, Cristian Popu, Vikram Oke, Briccio S Cadiz","doi":"10.1155/crom/6693120","DOIUrl":"10.1155/crom/6693120","url":null,"abstract":"<p><p>Lenalidomide is widely used for the treatment and maintenance of multiple myeloma and is generally considered to have a favorable safety profile. However, severe skeletal muscle toxicity associated with lenalidomide has been rarely reported. We describe a 52-year-old man with multiple myeloma who developed acute bilateral lower-extremity pain, cramping, weakness, and paresthesia while receiving lenalidomide therapy. Laboratory evaluation revealed marked rhabdomyolysis, and imaging and clinical findings were consistent with bilateral lower-leg compartment syndrome. Despite emergent bilateral fasciotomies resulting in resolution of pain and normalization of creatine kinase levels, the patient developed persistent bilateral foot drop with residual sensory deficits. To our knowledge, this represents the first reported case of lenalidomide-associated rhabdomyolysis progressing to bilateral compartment syndrome with permanent neurologic sequelae. This case underscores the importance of early recognition of muscle toxicity, prompt laboratory evaluation, and timely surgical intervention to mitigate irreversible functional impairment.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"6693120"},"PeriodicalIF":0.6,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13547945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148905301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic Small Cell Neuroendocrine Carcinoma of the Prostate: A Rare and Aggressive Case Report From Bangladesh. 转移性前列腺小细胞神经内分泌癌:孟加拉国一例罕见的侵袭性病例报告。
IF 0.6
Case Reports in Oncological Medicine Pub Date : 2026-09-03 eCollection Date: 2026-01-01 DOI: 10.1155/crom/2821229
Md Arifur Rahman, Zinia Jannat Ananna, Mostofa Arafat Islam, Hasin Mesbah Bin Siddique, Mashud Parvez, Sayem Hossain
{"title":"Metastatic Small Cell Neuroendocrine Carcinoma of the Prostate: A Rare and Aggressive Case Report From Bangladesh.","authors":"Md Arifur Rahman, Zinia Jannat Ananna, Mostofa Arafat Islam, Hasin Mesbah Bin Siddique, Mashud Parvez, Sayem Hossain","doi":"10.1155/crom/2821229","DOIUrl":"10.1155/crom/2821229","url":null,"abstract":"<p><strong>Background: </strong>Small cell neuroendocrine carcinoma of the prostate (SCNEC) is a rare but devastatingly aggressive malignancy, carrying a median survival well under 13 months even with multimodal treatment. It may arise de novo or emerge as a treatment-resistance phenotype following androgen deprivation in conventional prostatic adenocarcinoma. A defining and clinically treacherous feature is its failure to elevate serum PSA in proportion to tumour burden-a phenomenon termed the 'PSA paradox'-which routinely delays diagnosis, particularly in resource-limited settings.</p><p><strong>Case presentation: </strong>We report a 35-year-old Bangladeshi man who presented with obstructive urinary symptoms, constipation and deep pelvic pain. His serum PSA was only 0.77 ng/mL despite a 6.5 × 6.0 × 5.5 cm prostate mass with liver metastases, extensive osteoblastic bone deposits (SUVmax ~18 on 18F-FDG PET/CT), left hydronephrosis and regional lymphadenopathy. Initial TRUS-guided biopsy was reported as Gleason 5 + 5 = 10 adenocarcinoma. Given the PSA-disease burden mismatch, biopsy slides were immediately re-evaluated; haematuria and acute urinary retention necessitated urgent TURP on 4 December 2024, which confirmed a pure de novo SCNEC with diffuse synaptophysin positivity and a Ki-67 index exceeding 60%. GATA3 and p40 were negative. Renal function was confirmed adequate before platinum therapy following palliative TURP(serum creatinine 1.2 mg/dL); etoposide-cisplatin (EP) chemotherapy was administered for six cycles with standard hydration, achieving a marked metabolic response on interim PET/CT. Consolidative pelvic IMRT (55 Gy/20 fractions) followed. Despite this approach, the disease relapsed within 3 months; second-line docetaxel produced no meaningful response. The patient died approximately 11 months from diagnosis.</p><p><strong>Conclusions: </strong>This case underscores the critical importance of recognising the PSA paradox in younger patients with bulky pelvic disease, the indispensable role of a comprehensive IHC panel in confirming the neuroendocrine phenotype and the urgent need for novel therapeutic strategies in this near-universally lethal malignancy.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2026 ","pages":"2821229"},"PeriodicalIF":0.6,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13542580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148896577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书